DPHARM 2026
The future of drug development demands more than incremental improvements. As science becomes increasingly complex and development ecosystems continue to evolve, sponsors need partners who can simplify complexity, adapt at scale and help accelerate the delivery of life-changing therapies.
At DPHARM, discover how Syneos Health is helping shape the future of adaptive drug development through flexible operating models, deep therapeutic and operational expertise, AI-enabled innovation and patient-centered execution. From designing fit-for-purpose delivery models and reducing site and patient burden to applying intelligent technologies that improve predictability, trial execution and decision-making, we're helping sponsors navigate change with confidence and transform complexity into competitive advantage.
Meet with Us
Find our team at booth #101 and on the stage to learn how our integrated approach combines clinical expertise, advanced technology and scalable delivery to support every stage of the development lifecycle. Whether you're exploring new operating models, looking to improve trial performance or preparing for what's next in clinical development, we'll share practical insights and strategies to help you chart tomorrow with greater agility and impact.
Featured Sessions
FIRESIDE CHAT | Navigating Future-Forward Drug Development: Benchmarking Today
September 16 | 9:25-9:40am
Kenneth Getz, MBA
Director and Professor
Tufts Center for the Study of Drug Development
Tufts University School of Medicine
Michael Brooks
Chief Operating Officer
Syneos Health
PANEL | Navigating Future-Forward Drug Development: Charting Tomorrow
September 16 | 9:40-10:10am
Michael Brooks
Chief Operating Officer
Syneos Health
Diana Cucos
President, FSP 360 and Modular Solutions
Syneos Health
David Carruthers
VP, Head of Global Clinical Operations
BioPharmaceuticals R&D
AstraZeneca
Candice Fitzgerald
VP, Trial Operations, EUCAN
Novo Nordisk
Gina Klayman
VP, Head of Clinical Study Units, Americas
Head of Vendor Performance Management
Sanofi
The Hidden Cost of Control: Rethinking Oversight in Clinical Development
September 16 | 3:35-3:55pm
Diana Cucos
President, FSP 360 and Modular Solutions
Syneos Health
Elspeth Carnan, PhD
VP, Head of Trial Delivery Support
BMS
Related Content:
Want to learn more? Explore Insights Hub for our latest perspectives or click the resources below:
